Moderna included almost 4,000 youngsters in its study, with two thirds given the US-made jab. None of the children were hospitalised or died from the virus and no safety concerns were spotted.
Moderna included almost 4,000 youngsters in its study, with two thirds given the US-made jab. None of the children were hospitalised or died from the virus and no safety concerns were spotted.